Tissue Multiplex Analyte Detection in Anatomic Pathology – Pathways to Clinical Implementation
Open Access
- 27 July 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
Abstract
Background: Multiplex tissue analysis has revolutionized our understanding of the tumor microenvironment (TME) with implications for biomarker development and diagnostic testing. Multiplex labeling is used for specific clinical situations, but there remain barriers to expanded use in anatomic pathology practice. Methods: We review immunohistochemistry (IHC) and related assays used to localize molecules in tissues, with reference to United States regulatory and practice landscapes. We review multiplex methods and strategies used in clinical diagnosis and in research, particularly in immuno-oncology. Within the framework of assay design and testing phases, we examine the suitability of multiplex immunofluorescence (mIF) for clinical diagnostic workflows, considering its advantages and challenges to implementation. Results: Multiplex labeling is poised to radically transform pathologic diagnosis because it can answer questions about tissue-level biology and single-cell phenotypes that cannot be addressed with traditional IHC biomarker panels. Widespread implementation will require improved detection chemistry, illustrated by InSituPlex technology (Ultivue, Inc., Cambridge, MA) that allows coregistration of hematoxylin and eosin (H&E) and mIF images, greater standardization and interoperability of workflow and data pipelines to facilitate consistent interpretation by pathologists, and integration of multichannel images into digital pathology whole slide imaging (WSI) systems, including interpretation aided by artificial intelligence (AI). Adoption will also be facilitated by evidence that justifies incorporation into clinical practice, an ability to navigate regulatory pathways, and adequate health care budgets and reimbursement. We expand the brightfield WSI system “pixel pathway” concept to multiplex workflows, suggesting that adoption might be accelerated by data standardization centered on cell phenotypes defined by coexpression of multiple molecules. Conclusion: Multiplex labeling has the potential to complement next generation sequencing in cancer diagnosis by allowing pathologists to visualize and understand every cell in a tissue biopsy slide. Until mIF reagents, digital pathology systems including fluorescence scanners, and data pipelines are standardized, we propose that diagnostic labs will play a crucial role in driving adoption of multiplex tissue diagnostics by using retrospective data from tissue collections as a foundation for laboratory-developed test (LDT) implementation and use in prospective trials as companion diagnostics (CDx).Keywords
This publication has 147 references indexed in Scilit:
- Impact of CD68/(CD3+CD20) Ratio at the Invasive Front of Primary Tumors on Distant Metastasis Development in Breast CancerPLOS ONE, 2012
- Programming in Situ Immunofluorescence Intensities through Interchangeable Reactions of Dynamic DNA ComplexesChemBioChem, 2012
- RNAscope: A Novel in Situ RNA Analysis Platform for Formalin-Fixed, Paraffin-Embedded TissuesThe Journal of Molecular Diagnostics, 2012
- Molecular mechanisms of antigen retrieval: antigen retrieval reverses steric interference caused by formalin-induced cross-linksBiotechnic & Histochemistry, 2009
- Molecular mechanisms of antigen retrieval: antigen retrieval reverses steric interference caused by formalin-induced cross-linksBiotechnic & Histochemistry, 2009
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical OutcomeScience, 2006
- Antibodies Immunoreactive With Formalin-Fixed Tissue Antigens Recognize Linear Protein EpitopesAmerican Journal of Clinical Pathology, 2006
- Immunohistochemical Detection of EGFR in Paraffin-embedded Tumor TissuesJournal of Histochemistry & Cytochemistry, 2004
- Microscopy‐based multicolor tissue cytometry at the single‐cell levelCytometry Part A, 2004
- Immunohistologic studies of lymphoma: past, present, and future.Journal of Histochemistry & Cytochemistry, 1980